Home / Market News / $MMSI

$MMSI news and market catalysts

The 14 most recent market catalysts affecting $MMSI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

14 catalysts 3 high impact 12 bullish 0 bearish Medical Devices
Nov 5, 2026 Corporate Catalyst Bullish Impact 65
Merit Medical Announces Positive Clinical Data from WRAPSODY Global Registry
Merit Medical Systems, Inc. released positive clinical data from its WRAPSODY Global registry, specifically for the AVF cohort. The study demonstrated strong 6-month patency rates …
Nov 2, 2026 Corporate Catalyst Bullish Impact 55
Barrington Research Raises Price Target on Merit Medical Systems to $116
Barrington Research raised its price target on Merit Medical Systems (MMSI) from $114 to $116, while reiterating an Outperform rating. This move is a direct response to the company…
Oct 30, 2026 Corporate Catalyst Neutral Impact 55
Analyst Updates for Merit Medical Systems, Inc.
On October 30, 2026, Merit Medical Systems, Inc. received updated research notes from Needham, Wells Fargo, and BTIG. Needham and BTIG reiterated 'Buy' ratings, while Wells Fargo m…
Oct 30, 2026 Corporate Catalyst Bullish Impact 55
Needham Maintains Buy Rating and Raises Price Target for Merit Medical Systems
Needham & Company maintained its 'Buy' rating on Merit Medical Systems and raised its price target to $106 from $101. This analyst action signals continued positive sentiment and a…
Oct 29, 2026 Corporate Catalyst Neutral Impact 65
Merit Medical Acquires Solo Pace, Inc.
Merit Medical has completed the acquisition of Solo Pace, Inc. for approximately $45 million, effective October 13, 2026. This move integrates Solo Pace's precision intraprocedural…
Oct 29, 2026 Corporate Catalyst Bullish Impact 92
Merit Medical Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Merit Medical's Q3 2026 results significantly surpassed expectations, driven by strong U.S. revenue growth and better-than-anticipated demand across both its Foundational and Thera…
Aug 3, 2026 Corporate Catalyst Bullish Impact 55
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94
Canaccord Genuity's analyst Jon Young has maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $85 to $94. This indicates a strengthened posit…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95
JP Morgan analyst Robbie Marcus maintained an 'Overweight' rating on Merit Medical Systems (MMSI) and significantly raised the price target from $77 to $95. This upward revision in…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $106
Piper Sandler analyst Jason Bednar has maintained an 'Overweight' rating on Merit Medical Systems (MMSI) and raised the price target from $96 to $106. This action signals increased…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $83
Wells Fargo analyst Larry Biegelsen updated his coverage on Merit Medical Systems, raising the price target from $74 to $83 while maintaining an 'Equal-Weight' rating. This action …
Jul 31, 2026 Corporate Catalyst Bullish Impact 92
Merit Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Also, Needham and BTIG raised their respective price targets on the stock.
This headline indicates a strong positive corporate catalyst for Merit Medical Systems. Better-than-expected earnings and raised guidance signal robust operational performance and …
Jul 31, 2026 Corporate Catalyst Bullish Impact 92
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results
Merit Medical Systems (MMSI) delivered a significant positive surprise in its Q2 earnings, beating analyst estimates on both the top and bottom lines. This strong performance, driv…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $101
Needham analyst Mike Matson maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $90 to $101. This action signals an analyst's increased convi…
Jul 31, 2026 Corporate Catalyst Bullish Impact 55
BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $105
BTIG analyst Sam Eiber maintained a 'Buy' rating on Merit Medical Systems (MMSI) and raised the price target from $100 to $105. This action signals a positive outlook from a reputa…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.